Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

1.2K
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

647
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
647
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

632
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
632
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

961
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
961
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

569
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
569

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials.

Heart rhythm·2017
Same author

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

Journal of the American College of Cardiology·2017
Same author

Baseline characteristics and event rates among anticoagulated patients with atrial fibrillation in practice and pivotal NOAC trials.

Data in brief·2017
Same author

Comparison of the CHA<sub>2</sub>DS<sub>2</sub>-VASc, CHADS<sub>2</sub>, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.

The American journal of cardiology·2017
Same author

State of the art: optimal medical therapy - competing with or complementary to revascularisation in patients with coronary artery disease?

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2017
Same author

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study.

JAMA cardiology·2017

Video Experimental Relacionado

Updated: May 7, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

31.4K

Muerte súbita después de un infarto de miocardio.

A Selcuk Adabag1, Terry M Therneau, Bernard J Gersh

  • 1Division of Cardiology, Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.

JAMA
|November 6, 2008
PubMed
Resumen

El riesgo de muerte cardíaca súbita después de un infarto de miocardio (IM) ha disminuido en 30 años. La insuficiencia cardíaca aumenta significativamente este riesgo, mientras que la isquemia recurrente no lo hace, según un estudio comunitario.

Más Videos Relacionados

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.5K
A Modified Simple Method for Induction of Myocardial Infarction in Mice
04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

4.1K

Videos de Experimentos Relacionados

Last Updated: May 7, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

31.4K
Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

29.5K
A Modified Simple Method for Induction of Myocardial Infarction in Mice
04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

4.1K

Área de la Ciencia:

  • Cardiología Cardiología.
  • Salud Pública La salud pública.
  • Epidemiología La epidemiología.

Sus antecedentes:

  • El riesgo de muerte cardíaca súbita (MCS) después del infarto de miocardio (IM) requiere una evaluación actualizada de la comunidad.
  • No se comprende bien el impacto de la isquemia recurrente y la insuficiencia cardíaca en el SCD post-MI.

Objetivo del estudio:

  • Para evaluar el riesgo de ECS después de un infarto de miocardio en un entorno comunitario.
  • Para determinar la influencia de la isquemia recurrente y la insuficiencia cardíaca en el riesgo de ECS.

Principales métodos:

  • Un estudio de vigilancia basado en la población de 2997 pacientes con MI en el condado de Olmsted, Minnesota (1979-2005).
  • Seguimiento hasta 2008 con SCD definido como muerte extrahospitalaria por enfermedad coronaria.
  • Comparación de la supervivencia observada con las tasas de supervivencia esperadas.

Principales resultados:

  • La incidencia de ECS fue del 1,2% a los 30 días y del 6,9% a los 5 años, significativamente más alta de lo esperado.
  • El riesgo de ECS ha disminuido significativamente con el tiempo (HR 0,62 para 1997-2005 frente a 1979-1987).
  • La insuficiencia cardíaca aumentó notablemente el riesgo de ECS (HR 4.20), mientras que la isquemia recurrente no lo hizo (HR 1.26).

Conclusiones:

  • El riesgo de SCD después del infarto de miocardio ha disminuido significativamente en la práctica comunitaria durante 30 años.
  • La insuficiencia cardíaca es un factor de riesgo independiente para la ECS post-MI.
  • La isquemia recurrente no se asocia de manera independiente con un mayor riesgo de ECS después del infarto de miocardio.